Annual EBITDA
-$9.89 M
+$4.96 M+33.41%
30 April 2024
Summary:
Alzamend Neuro annual earnings before interest, taxes, depreciation & amortization is currently -$9.89 million, with the most recent change of +$4.96 million (+33.41%) on 30 April 2024. During the last 3 years, it has fallen by -$5.00 million (-102.28%). ALZN annual EBITDA is now -124.18% below its all-time high of -$4.41 million, reached on 30 April 2020.ALZN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$949.70 K
-$112.30 K-13.41%
31 July 2024
Summary:
Alzamend Neuro quarterly earnings before interest, taxes, depreciation & amortization is currently -$949.70 thousand, with the most recent change of -$112.30 thousand (-13.41%) on 31 July 2024. Over the past year, it has increased by +$1.94 million (+67.13%). ALZN quarterly EBITDA is now -13.41% below its all-time high of -$837.40 thousand, reached on 30 April 2024.ALZN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$7.32 M
+$2.56 M+25.93%
31 July 2024
Summary:
Alzamend Neuro TTM earnings before interest, taxes, depreciation & amortization is currently -$7.32 million, with the most recent change of +$2.56 million (+25.93%) on 31 July 2024. Over the past year, it has increased by +$7.80 million (+51.57%). ALZN TTM EBITDA is now -482.69% below its all-time high of -$1.26 million, reached on 30 April 2020.ALZN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALZN EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +33.4% | +67.1% | +51.6% |
| 3 y3 years | -102.3% | +73.5% | +10.3% |
| 5 y5 years | -97.4% | - | - |
ALZN EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -102.3% | +33.4% | -13.4% | +82.5% | at high | +52.5% |
| 5 y | 5 years | -124.2% | +33.4% | -13.4% | +82.5% | -482.7% | +52.5% |
| alltime | all time | -124.2% | +33.4% | -13.4% | +82.5% | -482.7% | +52.5% |
Alzamend Neuro EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| July 2024 | - | -$949.70 K(+13.4%) | -$7.32 M(-25.9%) |
| Apr 2024 | -$9.89 M(-33.4%) | -$837.40 K(-68.4%) | -$9.89 M(-19.9%) |
| Jan 2024 | - | -$2.65 M(-8.4%) | -$12.35 M(-18.3%) |
| Oct 2023 | - | -$2.89 M(-17.8%) | -$15.12 M(-1.4%) |
| July 2023 | - | -$3.51 M(+6.5%) | -$15.33 M(+3.3%) |
| Apr 2023 | -$14.85 M(+20.6%) | -$3.30 M(-39.1%) | -$14.85 M(-3.7%) |
| Jan 2023 | - | -$5.42 M(+74.7%) | -$15.41 M(+22.8%) |
| Oct 2022 | - | -$3.10 M(+2.4%) | -$12.55 M(-3.7%) |
| July 2022 | - | -$3.03 M(-21.6%) | -$13.03 M(+5.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Apr 2022 | -$12.31 M(+151.9%) | -$3.87 M(+51.2%) | -$12.31 M(+27.4%) |
| Jan 2022 | - | -$2.56 M(-28.7%) | -$9.67 M(+18.4%) |
| Oct 2021 | - | -$3.58 M(+55.4%) | -$8.16 M(+38.9%) |
| July 2021 | - | -$2.31 M(+89.0%) | -$5.88 M(+20.2%) |
| Apr 2021 | -$4.89 M(+10.8%) | -$1.22 M(+15.8%) | -$4.89 M(-0.7%) |
| Jan 2021 | - | -$1.05 M(-18.9%) | -$4.92 M(+27.2%) |
| Oct 2020 | - | -$1.30 M(-1.4%) | -$3.87 M(+50.4%) |
| July 2020 | - | -$1.32 M(+4.8%) | -$2.57 M(+104.8%) |
| Apr 2020 | -$4.41 M(-12.0%) | -$1.26 M | -$1.26 M |
| Apr 2019 | -$5.01 M | - | - |
FAQ
- What is Alzamend Neuro annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Alzamend Neuro?
- What is Alzamend Neuro annual EBITDA year-on-year change?
- What is Alzamend Neuro quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Alzamend Neuro?
- What is Alzamend Neuro quarterly EBITDA year-on-year change?
- What is Alzamend Neuro TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Alzamend Neuro?
- What is Alzamend Neuro TTM EBITDA year-on-year change?
What is Alzamend Neuro annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of ALZN is -$9.89 M
What is the all time high annual EBITDA for Alzamend Neuro?
Alzamend Neuro all-time high annual earnings before interest, taxes, depreciation & amortization is -$4.41 M
What is Alzamend Neuro annual EBITDA year-on-year change?
Over the past year, ALZN annual earnings before interest, taxes, depreciation & amortization has changed by +$4.96 M (+33.41%)
What is Alzamend Neuro quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of ALZN is -$949.70 K
What is the all time high quarterly EBITDA for Alzamend Neuro?
Alzamend Neuro all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$837.40 K
What is Alzamend Neuro quarterly EBITDA year-on-year change?
Over the past year, ALZN quarterly earnings before interest, taxes, depreciation & amortization has changed by +$1.94 M (+67.13%)
What is Alzamend Neuro TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of ALZN is -$7.32 M
What is the all time high TTM EBITDA for Alzamend Neuro?
Alzamend Neuro all-time high TTM earnings before interest, taxes, depreciation & amortization is -$1.26 M
What is Alzamend Neuro TTM EBITDA year-on-year change?
Over the past year, ALZN TTM earnings before interest, taxes, depreciation & amortization has changed by +$7.80 M (+51.57%)